The global Lung Cancer Diagnostic and Screening Market is estimated to be valued at US$931.0 million in 2021 and is expected to exhibit a compound annual growth rate (CAGR) of 7.8% over the forecast period of 2021-2028.
Lung cancer is one of the deadliest forms of cancer worldwide, necessitating the need for effective diagnostic and screening techniques. The market offers advanced products designed to diagnose lung cancer at an early ... Read more
A) Market Overview:
The global Lung Cancer Diagnostic and Screening Marketis estimated to be valued at US$ 1,931.0 Mn in 2021 and is expected to exhibit a CAGR of 7.8% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Lung cancer is one of the most prevalent and life-threatening cancers globally. Timely diagnosis and screening play a vital role in enhancing survival rates and improving patient ... Read more
The lung cancer diagnostic and screening market encompasses various tools and technologies that are used to detect lung cancer at an early stage. There are several techniques such as imaging test, biomarkers test, endobronchial ultrasound-guided needle aspiration, and thoracic surgery that help diagnose and screen lung cancer.
The Global Lung Cancer Diagnostic and Screening Market is estimated to be valued at US$ 2243.98 Mn in 2023 and is expected to exhibit a CAGR of 42% ... Read more
The lung cancer diagnostic and screening market encompasses various tools and technologies that are used to detect lung cancer at an early stage. There are several techniques such as imaging test, biomarkers test, endobronchial ultrasound-guided needle aspiration, and thoracic surgery that help diagnose and screen lung cancer.
The global Lung Cancer Diagnostic And Screening Market is estimated to be valued at US$ 2243.98 Mn in 2023 and is expected ... Read more
Lung cancer diagnostic and screening market comprises various medical instruments, devices and consumables such as biomarkers, imaging tests, endobronchial ultrasound (EBUS) needles, biopsy forceps among others that are used in lung cancer diagnosis and screening to detect early stage lung cancer in asymptomatic individuals. The increasing cases of lung cancer globally is leading to high demand for effective lung cancer diagnostic tests and screening procedures.
